Pimecrolimus Completed Phase 2 Trials for Vitiligo Vulgaris Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00372307Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris